On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

A woman on Ozempic has revealed why she gave her 11 year old daughter weight loss jabs, a similar drug called Wegovy, on This Morning ...

National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

A WOMAN has shared the brutally honest truth about what happened when she was forced to ”go cold turkey” from Mounjaro.

A MOTHER who put her daughter on weight loss jabs at the age of 11 has opened up on her family’s experience with the ...

Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

It’s a controversial topic… Should we give weight-loss jabs to kids? Over in America, we meet mum Ashley Hamilton, who’s allowed her daughter, Sophia, to use Wegovy since she was just 11 years old.

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...